The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

Clinical trial NCT04404049 · UNKNOWN

Trial details

NCT number: NCT04404049
Sponsor: UBP Greater China (Shanghai) Co., Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2023-12-01
Primary completion: 2024-06-30
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.